|
HS Code |
641068 |
| Iupac Name | 2-amino-6-(hydroxymethyl)-1H-pyrimidin-4-one |
| Molecular Formula | C5H7N3O2 |
| Molecular Weight | 141.13 g/mol |
| Cas Number | 63-75-6 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 200-205°C |
| Solubility In Water | Freely soluble |
| Pka | 8.2 (approximate, for the amino group) |
| Synonyms | Thymine, 2-amino-6-hydroxymethyl-; 2-Amino-6-hydroxymethylpyrimidin-4(3H)-one |
| Structure Type | Heterocyclic aromatic compound |
| Pubchem Cid | 667 |
| Stability | Stable under recommended storage conditions |
As an accredited 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Brown glass bottle containing 25 grams, sealed with a screw cap, labeled with chemical name, quantity, hazard, and handling information. |
| Container Loading (20′ FCL) | 20′ FCL (Full Container Load) typically holds 12–14 MT of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)-, packed securely in drums. |
| Shipping | The chemical **4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)-** should be shipped in a tightly sealed container, protected from light and moisture. It must comply with all applicable transport regulations. Temperature-controlled shipping is recommended to maintain chemical stability. Ensure proper labeling and include safety documentation with the package for safe and compliant handling. |
| Storage | 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- should be stored in a tightly closed container, in a cool, dry, well-ventilated area, away from direct sunlight, sources of ignition, and incompatible substances such as strong oxidizing agents. It is advisable to keep the chemical at room temperature and protect it from moisture. Appropriate safety labeling and access control are recommended. |
| Shelf Life | Shelf life of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- is typically 2-3 years when stored cool, dry, and protected from light. |
Competitive 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists call it 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)-, but in our plant, it’s earned a reputation as a backbone intermediate in several synthesis routes. Knowledge collected from years in manufacturing continually reinforces its value. This compound has an accessible molecular structure for manipulations and functionalizations—the aminopyrimidinone core coupled with a hydroxymethyl side group. The model we offer consistently contains this signature arrangement. Many downstream products, especially in pharmaceuticals and crop protection, draw from this template. We never take for granted the impact of subtle structure changes, particularly when suppliers elsewhere substitute groups or modify side chains. We have learned that Klein tweaks at the molecular level ripple out to finished product performance.
Manufacturing prompts respect for purity and material profile, not theory alone. Our batches of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- regularly test above 99% assay, verified by HPLC and NMR under strict lab controls. Each lot carries a tight profile. Water content typically holds under 0.5%, and typical appearances range off-white to slightly beige, never the yellowish hues seen in lower-purity variants. We work with powdered and sometimes crystalline forms, observing that powder provides quicker dissolution for solution-based syntheses. Flowability in large reactor drums matters. Sticky or granular inconsistencies may suggest byproducts or incomplete crystallization from upstream, so we invest real time monitoring those properties. Our plant stores samples at controlled temperatures—not out of habit, but because degradation rates double every 10°C hike. Field experience has proven that, especially across long-haul shipping or during monsoon months.
Our main customers synthesize intermediates for anti-viral compounds or agricultural agents. Their process calls for a robust aminopyrimidinone base—no foul odors, and clean mass balance in analytical runs. The reactivity of the aminomethyl group stands out. At high pH or in alkylation protocols, this area of the molecule takes on substitutions that other skeletons simply cannot. This efficiency cuts synthesis steps, and experienced process engineers gravitate to this backbone for that reason. The hydroxymethyl arm at the 6-position markedly boosts solubility in polar media, which matters during process scale-up. Our prior experiments confirm that batches with low-hydroxymethyl signals in NMR suffer poor yields later on. Years in production solidify that every lot shipped must maintain that defining chemical logic.
Over the course of thousands of kilos produced, we’ve seen how subtle differences set this compound apart. Colleagues occasionally compare it to 2-amino-4(3H)-pyrimidinone or 2-hydroxymethyl-4,6-dihydroxypyrimidine, both of which appear similar in catalogs. Such analogs sometimes tempt buyers looking for a lower cost. Direct experience warns against this shortcut. For example, swapping out the hydroxymethyl group at the 6-position (or sourcing with uncontrolled isomer content) tends to decrease reactivity toward desired alkylations, leading to extra purification and more solvent waste. Our testing lines up with peer-reviewed reports: the capacity of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- to participate in selective functionalization at the amino position means short reaction times, reliable conversions, and a highly predictable profile in analog screening.
Another key difference lies in impurity handling. Similar core molecules from the market often retain urea, secondary amines, or colored byproducts that stem from hastier reaction conditions upstream. Over the years, we’ve refined our purification sequences, drawing from repeated scale-ups and pilot runs, so that our output suffers minimal batch-to-batch deviation. The function this serves is more than about specifications—it means consistently successful downstream syntheses for our partners. In pharmaceutical applications, side impurities present regulatory risks; real-world projects have stalled on account of trace contaminants entering a multistep synthesis. Our experience recommends focusing not just on the core assay figure, but on full impurity mapping through LC/MS and GC. Small investments here spare major headaches across regulatory review boards and quality departments.
We began large-scale production after collaborating with a university project seeking pyrimidine-based anti-virals. Their first pilot study drew from a commercial import that failed both purity and chemical identity checks, stalling their timeline. Running the synthesis with our compound, reaction completion hit 15% higher, and no extraneous peaks appeared during HPLC release. For chemists under pressure to meet preclinical timeframes, reproducibility of starting materials makes all the difference. In another situation, an agrochemical producer commissioned us for a run using a non-hydroxymethyl derivative sourced from another region. Testing in their active ingredient screen found dramatically reduced water solubility and lower field stability; the finished product failed the heat shock test. Repeating the synthesis with our prepared 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- restored stability, supported a robust formulation, and helped clear product registrations in two countries.
We support research teams with custom lots shaped by their feedback. Some ask for specific particle sizes for improved suspension in organic carrier liquids, others require precise impurity mapping for regulatory dossiers. Every requirement comes from a real process, never just from technical datasheets. Our lab-scale batches now serve as NMR calibration standards for a handful of pharma labs overseas, as their analysts report that our spectral fingerprints permit rapid ID without secondary cleanup. The stories that resonate most with us center on bottlenecks resolved or projects finishing early, thanks to consistent materials. These lessons travel up and down manufacturing—batch tank operators, lab techs, and quality managers all know they can rely on the same material day after day.
Some decision makers see fine chemical supply as a cost center. From our position, stability and batch predictability cut costs in unexpected places. Storage longevity has become a universal concern as energy costs rise; our 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- last reviewed at four years under climate-controlled storage with less than 0.2% assay decrease and no change in appearance. This stability profile, measured across routine retention testing, shields users from last-minute revalidation. Research projects faced with material recall or failed QC find themselves weeks behind, often at massive expense. By controlling humidity, oxygen, and packaging integrity, we guarantee extended shelf life, and our plant staff mark every shipment for feedback, tracking conditions from warehouse shelf to the user’s fume hood.
Packaging presents its own set of lessons. Early on, packaging in high-density polyethylene drums gave some batches a faint plastic odor after several months. Through trial—and learning from customer feedback—we migrated to lined fiber drums for bulk, with strict sealing. UV-exposed product shows discoloration in days, so our logistics team packs every order in opaque secondary wraps. These steps grew out of requests from formulation chemists who traced batch-to-batch differences back to improper transport. Nothing beats real-world usage data for guiding improvements in packaging and shipping.
We track every reaction step both in lab logs and at the plant, ensuring each production batch bears its synthesis path. Traceability extends from raw materials—pulled from vetted suppliers with audit histories—to finished product QR codes for tracking. Each year, auditors review our compliance systems, and our own staff conduct routine verifications to spot any slippage in records. Regulatory teams from EU and East Asian pharmaceutical clients value this traceability, as it expedites their review and release cycles. In one audit, a drugmaker flagged a suspected out-of-spec lot as cause for review; pulling the synthesis record and upstream material QC showed the deviation stemmed from a single change in crystallization temperature, rapidly identified and corrected. This level of control wouldn’t exist without hands-on experience in both production and regulatory regimes.
Some entry-level producers shortchange this step to rush batches out the door. Over time, gaps in record-keeping catch up; an isolated incident might seem minor but often signals systemic weakness. Our commitment as a chemical manufacturer means the paper trail—digital and physical—follows every gram from synthesis vessel to shipment. It’s not a paperwork chore; it’s about certainty for everybody touching the supply line. During the pandemic, disruptions rocked supply in multiple regions, and companies with clean batch lineage fared better with regulatory waivers and supply continuity.
Every new synthesis batch starts with inputs from customer feedback. Our plant maintains lines of communication with process engineers, lab analysts, and project managers. If a user flags particle size distribution or new impurity peaks, we run internal checks, analyze root causes, and adjust protocols if needed. Several years ago, a project team approached us about residual solvent signals in their final API. Together, we investigated at the removal step in our own plant, updating our purification sequence to remove those solvents. Once these improvements were validated, they entered our SOPs. Savings came full circle for both us and our customer—they saved time and solvent, we reduced post-packaging reprocessing, and batch releases turned quicker.
This cultivates a partnership built on technical trust. As a manufacturer, we see the direct impact of even minor material deviations—whether it’s a different absorbance curve on QC or a drop in yield at a critical step. Feedback from the floor, not just management, shapes our standards. Our lab staff handle retention samples, monitoring them alongside new batches. They don’t just tick boxes—they track real analytical histories and flag slow or gradual drift. Seasoned production operators know every shortcut translates into a problem later on, so our commitment reaches every cylinder, flask, and shipping drum marked with our labels.
No production process comes free of hurdles. The chemical nature of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- means it attracts atmospheric moisture. Facilities storing open product often report lumping or even partial dissolution, especially in suboptimal warehouses. During a heat wave one summer, we logged clumping complaints from three areas with compromised HVAC. Our team quickly redesigned packaging protocols, adding additional moisture barriers and beefing up warehousing controls. Since then, complaints have dropped to near zero. No theory replaces the lesson learned from batches caked into blocks on a shelf or the hands-on effort required to chisel them free.
Customers scaling to pilot plants sometimes find unanticipated solubility or filtration issues. Recently, a user attempted to shift a process from 20 g lab scale to 10 kg reactor. Yield dropped, prompting troubleshooting across every upstream variable. Analyzing both our batch and their protocol, the solution came from tweaking pH during dissolution—too acidic, and partial hydrolysis caused yield loss. This experience sits among dozens encountered over the years: real-world plant data often teaches lessons that aren’t found in textbooks or product notes. Bringing these cases back to our R&D staff, we continue to adapt and create data resources, helping future projects approach scale-up with more confidence.
Modern specialty chemical manufacturing faces ever-evolving environmental requirements. By working directly in the industry, we appreciate firsthand how solvent selection, energy use, and air handling make a difference on emissions and waste. At our own plant, progressive upgrades have cut solvent losses and improved recycling rates. Across the years, we watched how seemingly minor reworks—such as switching to in-line solvent recovery—culminate in measurable reductions in effluent. A zero-tolerance approach to solvent venting now means any vapor loss beyond the monitored standard triggers investigation. This diligence carries over to every batch of 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- we produce.
During batch reactions, we keep a close eye on energy use, as thermal regulation accounts for a significant portion of costs and, indirectly, carbon footprint. By adhering to optimized temperature curves and staged additions, we avoid runaway reactions and minimize utility demand. Downstream, water discharge quality matches regulatory discharge limits for every shipment. Nothing compares to standing at the outflow line, sampling water yourself, and knowing that every ppm matters both for compliance and reputation. Local regulators and visiting clients now conduct their own tests on site, and these audits always reinforce the value of rigorous process control. Technical improvements in this area further reinforce trust for both authorities and our customers.
As a chemical producer, regulatory scrutiny becomes a daily companion. Our production and QC teams live with the reality that missing a regulatory target means lost time and credibility. Clients working on clinical pathways require clean analytical data packs, full traceability, and cross-validation with their own controls. In the early days, documentation sometimes lagged behind process improvements; that changed after an international review flagged gaps between process change and retained test samples. Since then, every SOP and deviation goes through periodic review updates.
Navigating regulatory frameworks across multiple regions introduces complexity. Some markets, for example, require genotoxin screening, while others focus on elemental impurities. Our QC staff has trained to match these requirements batch by batch, allowing export certificates and customer regulatory filings to proceed without delay. Situations have arisen where an incoming shipment to a customer halted at a port due to incomplete or mismatched documentation; recalling thorough training and redundant checks, our team pulled retained samples and analytical runs within hours, smoothing clearance. Experiences like this, while stressful, strengthen our systems and deepen relationships with quality contacts worldwide.
The shape of progress in specialty chemicals comes from what end users dream up and what makers can deliver. Over decades, those requests—faster solubility, lower dusting, narrower impurity windows—have shaped every process tweak. Some of our research partners hope to tap this molecule in diagnostics, others for innovative crop protection. Every new demand means new specifications to meet, new analytics to verify, and new shipping challenges to solve. As a hands-on manufacturer, we stand inside that cycle, meeting changing technical needs and responding with process innovation, not standing still.
Industry doesn’t stop evolving. As regulations grow tighter, technical questions tougher, and new application spaces open up, the lessons from years in production—each challenge met, each problem solved—anchor every gram produced in experience, responsibility, and commitment. The next breakthrough always begins with the right building blocks. Our ongoing dedication ensures 4(3H)-Pyrimidinone, 2-amino-6-(hydroxymethyl)- remains a foundation that scientists, process engineers, and innovators can trust, project after project.